Search Within

HEMATOLOGICAL MALIGNANCIES

Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 17
Page: 3068-3079
Authors: Lu Hao, Tongtong Li, Lung-Ji Chang* and Xiaochuan Chen*

The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 12
Page: 2208-2229
Authors: Dora Visnjic*, Vilma Dembitz and Hrvoje Lalic

Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 6
Page: 1002-1018
Authors: Pavel Klener Jr, Tomas Etrych and Pavel Klener*

Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 14
Page: 1936-1951
Authors: Raghav Dogra, Rohit Bhatia, Ravi Shankar, Parveen Bansal and Ravindra K. Rawal*

Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 30
Page: 2584-2598
Authors: Venkatesh Chanukuppa, Ravindra Taware, Tathagat Chatterjee, Sanjeevan Sharma, Tushar H. More, Khushman Taunk, Saravanan Kumar, Manas K. Santra and Srikanth Rapole*

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19, Issue: 1
Page: 51-78
Authors: Ota Fuchs*

Antitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 10
Page: 1457-1468
Authors: Michelle X.G. Pereira, Amanda S.O. Hammes, Flavia C. Vasconcelos, Aline R. Pozzo, Thaís H. Pereira, Ernesto R. Caffarena, Cerli R. Gattass and Raquel C. Maia*

Combination Treatment of p53-Null HL-60 cells with Histone Deacetylase Inhibitors and Chlorambucil Augments Apoptosis and Increases BCL6 and p21 Gene Expression

Journal: Current Molecular Pharmacology
Volume: 12, Issue: 1
Page: 72-81
Authors: Faith A.A. Kwa*, Merrole F. Cole-Sinclair and Miroslav K. Kapuscinski

Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 35
Page: 4535-4544
Authors: Annalisa Ruggeri*, Annalisa Paviglianiti, Fernanda Volt, Chantal Kenzey, Hanadi Rafii, Vanderson Rocha and Eliane Gluckman

Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

Journal: Current Radiopharmaceuticals
Volume: 11, Issue: 3
Page: 192-199
Authors: Joseph G. Jurcic*

Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads

Journal: Current Signal Transduction Therapy
Volume: 13, Issue: 2
Page: 83-104
Authors: Sisir Nandi*, Mohd Salman, Ankita Sharma and Mohit Kumar

Recent Progress in Clinical Development of Therapeutic Antibodies Targeting Glycan-Binding Proteins

Journal: Current Drug Targets
Volume: 19, Issue: 13
Page: 1491-1497
Authors: Qun Zhou*

Pegylated Naloxone in the Treatment of Persistent Opioid-Induced Constipation in Patients with Hematological Malignancies

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 16, Issue: 1
Page: 3-4
Authors: Gregorio Antonio Brunetti, Giovanna Palumbo, Giorgia Annechini, Michelina Santopietro, Andrea Tendas*, Pasquale Niscola* and Claudio Cartoni

Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance

Journal: Current Rheumatology Reviews
Volume: 14, Issue: 2
Page: 131-139
Authors: Rossella Talotta*, Fabiola Atzeni, Alberto Batticciotto, Maurizio Benucci, Sara Bongiovanni and Piercarlo Sarzi-Puttini

Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 24
Page: 2811-2825
Authors: Raffaella Franca, Natasa K. Kuzelicki, Claudio Sorio, Eleonora Toffoletti, Oksana Montecchini, Alice Poropat, Marco Rabusin*, Debora Curci, Dino Paladin, Gabriele Stocco and Giuliana Decorti

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 6
Page: 608-616
Authors: Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, Alessandro Casellato, Paolo Macaccaro, Laura Quotti Tubi, Andrea Visentin, Livio Trentin, Gianpietro Semenzato and Francesco Piazza*

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 2
Page: 159-183
Authors: Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin

Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 5
Page: 564-575
Authors: Chuanqing Wu, Tuo Ruan, Weizhen Liu, Xiaojie Zhu, Juan Pan, Wen Lu, Chen Yan, Kaixiong Tao , Weikang Zhang* and Chun Zhang*

Detection of Formation of Recombinant Human Keratinocyte Growth Factor Loaded Chitosan Nanoparticles Based on its Optical Properties

Journal: Current Nanoscience
Volume: 14, Issue: 2
Page: 127-135
Authors: Palanirajan Vijayaraj Kumar*, Marwan Abdelmahmoud Abdelkarim Maki, Mhd Luay Takahje, Yeong Siew Wei, Lee Ming Tatt and Abu Bakar Bin Abdul Majeed

Cell Cycle Arrest and Apoptosis Induction Activity of Nitidine Chloride on Acute Myeloid Leukemia Cells

Journal: Medicinal Chemistry
Volume: 14, Issue: 1
Page: 60-66
Authors: Peng Li, Shuxin Yan, Xin Dong, Zhao Li, Yu Qiu, Chunyan Ji, Jingru Zhang, Min Ji, Wei Li, Hongchun Wang, Zhi Liu, Xing L. Wang, Jingjing Ye* and Daoxin Ma

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 9
Page: 819-838
Authors: Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone*

Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 28
Page: 3025-3053
Authors: Agnieszka Dreas, Maciej Mikulski, Mariusz Milik, Charles-Henry Fabritius, Krzysztof Brzózka and Tomasz Rzymski*

Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 9
Page: 1267-1277
Authors: Ximena Camacho, Camila Longo Machado, Maria Fernanda García, Marcelo Fernández, Natalia Oddone, Juan Benech, Juan Pablo Gambini, Hugo Cerecetto, Roger Chammas, Pablo Cabral and Eloisa Riva*

Characteristics of Peripheral Blood Stem Cells: 2D-Gel Electrophoresis and Kinetic Parameter of Exocytosis

Journal: Current Biomarkers (Under Re-organization)
Volume: 6, Issue: 2
Page: 113-123
Authors: Jiraporn Kantapan, Nutthapong Moonkum, Saranya Jaruchainiwat, Wipob Suttana, Padchanee Sangthong and Samlee Mankhetkorn*

Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 7
Page: 886-895
Authors: Alberto Fabbri*, Emanuele Cencini, Alessandro Gozzetti, Luana Schiattone and Monica Bocchia

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 5
Page: 423-444
Authors: Dariush Shanehbandi, Jafar Majidi*, Tohid Kazemi*, Behzad Baradaran and Leili Aghebati-Maleki

Chemotherapy and Cardiotoxicity in Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 4
Page: 311-324
Authors: Antonio Stellitano, Roberta Fedele, Santina Barilla, Antonino Iaria, Carmelo Massimiliano Rao and Massimo Martino*

Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 8
Page: 1167-1174
Authors: Dimitry A. Chistiakov, Veronika A. Myasoedova, Alexander N. Orekhov and Yuri V. Bobryshev*

Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles

Journal: Current Gene Therapy
Volume: 16, Issue: 6
Page: 390-400
Authors: Yingzhe Jiang, Bing Xia, Yizhuo Zhang* and Wen Xu

Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 1
Page: 95-107
Authors: Chandrika Gowda, Mansi Sachdev, Sunil Muthusami, Malika Kapadia, Lidija Petrovic-Dovat, Melanie Hartman, Yali Ding, Chunhua Song, Jonathon L. Payne, Bi-Hua Tan and Sinisa Dovat

Targeting Notch as a Therapeutic Approach for Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 1
Page: 108-134
Authors: Natalia Platonova, Elena Lesma, Andrea Basile, Monica Bignotto, Silvia Garavelli, Maria Teresa Palano, Adriana Moschini, Antonino Neri, Michela Colombo and Raffaella Chiaramonte

Rheumatologic Manifestations of Hematologic Neoplasms

Journal: Current Rheumatology Reviews
Volume: 13, Issue: 1
Page: 51-58
Authors: A. Wang, C. M. Brunet and A. M. Zeidan

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells

Journal: Current Drug Targets
Volume: 18, Issue: 3
Page: 271-280
Authors: Conrad R.Y. Cruz and Catherine M. Bollard

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

Journal: Current Genomics
Volume: 18, Issue: 1
Page: 3-26
Authors: Katrin Sak and Hele Everaus

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment

Journal: Current Drug Targets
Volume: 18, Issue: 1
Page: 35-55
Authors: Gabriella Misso, Mayra Rachele Zarone, Anna Grimaldi, Maria Teresa Di Martino, Angela Lombardi, Hiromichi Kawasaki, Paola Stiuso, Pierfrancesco Tassone, Pierosandro Tagliaferri and Michele Caraglia

Novel Immunotherapies for Hematological Malignancies

Journal: Current Molecular Pharmacology
Volume: 9, Issue: 3
Page: 264-271
Authors: Monali Vasekar, Syed Rizvi, Xin Liu, Kent E. Vrana and Hong Zheng

The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions

Journal: Current Diabetes Reviews
Volume: 12, Issue: 3
Page: 231-239
Authors: Eyad Hamoudeh, Amer M. Zeidan, Lisa Barbarotta and Nina Rosano

Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14, Issue: 1
Page: 68-74
Authors: Gregorio A. Brunetti, Giovanna Palumbo, Giacomo S. Morano, Erminia Baldacci, Ida Carmosino, Giorgia Annechini, Romina Talone, Sara Kiflom, Giada Mastrogiacomo, Sara Grammatico, Marta Chisini, Adriana Costa, Andrea Tendas, Laura Scaramucci, Marco Giovannini, Pasquale Niscola, Maria T. Petrucci and Claudio Cartoni

Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art

Journal: Current Drug Targets
Volume: 17, Issue: 9
Page: 1072-1082
Authors: Magdalena Witkowska and Piotr Smolewski

Yin and Yang of Polyphenols in Cancer Prevention: A Short Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16, Issue: 7
Page: 832-840
Authors: Jolie Kiemlian Kwee

Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study

Journal: Infectious Disorders - Drug Targets
Volume: 16, Issue: 1
Page: 54-62
Authors: Adel A. Hagag, Samir M. Hassan, Mohamed A. Elgamasy and Ibtesam K. Afifi

Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases

Journal: Current Medicinal Chemistry
Volume: 23, Issue: 12
Page: 1217-1238
Authors: Roberta Ettari, Santo Previti, Alessandra Bitto, Silvana Grasso and Maria Zappalà

Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 16
Page: 2315-2322
Authors: Marie Levade, Sonia Severin, Marie-Pierre Gratacap, Loïc Ysebaert and Bernard Payrastre

Acute Lymphoblastic Leukemia and Regulatory T cells: Biomarkers and Immunopathogenesis

Journal: Current Immunology Reviews
Volume: 12, Issue: 1
Page: 14-19
Authors: Carlos H. Hiroki, Rafaela P. Erthal, Ana P.L. Pereira, Letícia M. Pacholak, Thiago C. Fujita, Poliana C. Marinello, Idessânia N. Costa, Sérgio P.D. da Rocha, Maria A.E. Watanabe and Carlos E.C. de Oliveira

Predictive Factors of Febrile Neutropenia Induced by Anticancer Chemotherapy in the South of Tunisia

Journal: Reviews on Recent Clinical Trials
Volume: 11, Issue: 1
Page: 72-76
Authors: Afef Khanfir, Wala Ben Kridis, Safia Masmoudi, Senda Mezghani, Adnen Hammami and Mounir Frikha

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies

Journal: Clinical Cancer Drugs
Volume: 2, Issue: 2
Page: 100-111
Authors: Benny Johnson and Daruka Mahadevan

Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 15, Issue: 9
Page: 769-780
Authors: Lei Cao, Lei Fan, Wei Xu and Jian-Yong Li

Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 9
Page: 1127-1133
Authors: Yanan Jiang and Lijun Jia

MicroRNAs in Myeloid Hematological Malignancies

Journal: Current Genomics
Volume: 16, Issue: 5
Page: 336-348
Authors: Maria Ciccone and George Adrian Calin

MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 15, Issue: 1
Page: 53-70
Authors: Xin Li, Xin A. Zhang, Wei Xie, Xiaoqing Li and Shiang Huang

Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies

Journal: Current Pharmaceutical Biotechnology
Volume: 15, Issue: 11
Page: 1083-1092
Authors: Zichu Zhao and Yan Chen

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Journal: Current Topics in Medicinal Chemistry
Volume: 14, Issue: 13
Page: 1574-1589
Authors: Won-Tak Choi, Yilei Yang, Yan Xu and Jing An

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 14, Issue: 6
Page: 537-548
Authors: Zachary Miller, Wooin Lee and Kyung Bo Kim

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 27
Page: 3173-3187
Authors: J. Zhu, M. Wang, B. Cao, T. Hou and X. Mao

Expression and Function of the Transient Receptor Potential Ion Channel Family in the Hematologic Malignancies

Journal: Current Molecular Pharmacology
Volume: 6, Issue: 3
Page: 137-148
Authors: Maria B. Morelli, Sonia Liberati, Consuelo Amantini, Massimo Nabiss, Matteo Santoni, Valerio Farfariello and Giorgio Santoni

The Influence of Cox-2 and Bioactive Lipids on Hematological Cancers

Journal: Current Angiogenesis (Discontinued)
Volume: 2, Issue: 2
Page: 135-142
Authors: Sesquile Ramon, Collynn F. Woeller and Richard P. Phipps

Editorial (Thematic Issue: Neovascularization in Hematological Malignancies: Biologic and Clinical Implications)

Journal: Current Angiogenesis (Discontinued)
Volume: 2, Issue: 2
Page: 75-75
Authors: Marie-Christine Kyrtsonis

Editorial (microRNA Aberrations and Their Role in Supporting Hematologic Malignancies)

Journal: MicroRNA
Volume: 2, Issue: 3
Page: 157-157
Authors: Aldo M. Roccaro and Irene M. Ghobrial

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

Journal: Current Topics in Medicinal Chemistry
Volume: 13, Issue: 23
Page: 2955-2964
Authors: Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Francesca Arruga, Davide Brusa, Roberta Buonincontri, Branimir Gizdic and Silvia Deaglio

The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 9
Page: 1444-1448
Authors: Marilia Rita Pinzone, Massimiliano Berretta, Hans Wilhelm Doerr, Giuseppe Nunnari and Bruno Cacopardo

From Bortezomib to other Inhibitors of the Proteasome and Beyond

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 22
Page: 4025-4038
Authors: Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou

Inhibitors of the Immunoproteasome: Current Status and Future Directions

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 22
Page: 4140-4151
Authors: Zachary Miller, Lin Ao, Kyung Bo Kim and Wooin Lee

Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells

Journal: Current Medicinal Chemistry
Volume: 20, Issue: 21
Page: 2712-2722
Authors: R. Voltan, P. Secchiero, B. Ruozi, L. Caruso, F. Forni, M. Palomba, G. Zauli and M.A. Vandelli

Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 20
Page: 3569-3594
Authors: Meinolf Karthaus and Dieter Buchheidt

Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 20
Page: 3689-3712
Authors: Thomas Lehrnbecher, Markus Kalkum, Jackson Champer, Lars Tramsen, Stanislaw Schmidt and Thomas Klingebiel

Oleocanthal Inhibits Proliferation and MIP-1α Expression in Human Multiple Myeloma Cells

Journal: Current Medicinal Chemistry
Volume: 20, Issue: 19
Page: 2467-2475
Authors: M. Scotece, R. Gomez, J. Conde, V. Lopez, J.J. Gomez-Reino, F. Lago, A.B. Smith III and O. Gualillo

Molecular Mechanism of Anti-tumor Effect by Triptolide in Hematological Malignancies

Journal: Current Signal Transduction Therapy
Volume: 8, Issue: 1
Page: 84-90
Authors: Youping Wang and Yan Chen

The Current and Future Therapies for Human Osteosarcoma

Journal: Current Cancer Therapy Reviews
Volume: 9, Issue: 1
Page: 55-77
Authors: Joseph D. Lamplot, Sahitya Denduluri, Jiaqiang Qin, Ruidong Li, Xing Liu, Hongyu Zhang, Xiang Chen, Ning Wang, Abdullah Pratt, Wei Shui, Xiaoji Luo, Guoxin Nan, Zhong-Liang Deng, Jinyong Luo, Rex C Haydon, Tong-Chuan He and Hue H. Luu

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 4
Page: 734-744
Authors: Michele Cea, Antonia Cagnetta, Marco Gobbi, Franco Patrone, Paul G. Richardson, Teru Hideshima and Kenneth C. Anderson

State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 28
Page: 4875-4884
Authors: G. Zauli, R. Voltan, V. Tisato and P. Secchiero

Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 25
Page: 4298-4305
Authors: D. Xiang, V.R. Sharma, C.E. Freter and J. Yan

Invasive aspergillosis: adjunctive combination therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12, Issue: 12
Page: 1261-1272
Authors: Sonam Ruhil, Meenakshi Balhara, Sandeep Dhankhar, Vikash Kumar and A.K. Chhillar

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12, Issue: 8
Page: 891-901
Authors: Min Shen, Tak Hang Chan and Q. Ping Dou

Continuous Renal Replacement Therapy in Children Post-Hematopoietic Stem Cell Transplantation: The Present and the Future

Journal: Current Stem Cell Research & Therapy
Volume: 7, Issue: 5
Page: 381-387
Authors: Lama Elbahlawan and R. Ray Morrison

Significance of Genome-Wide Analysis of Copy Number Alterations and UPD in Myelodysplastic Syndromes using Combined CGH – SNP Arrays

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 22
Page: 3739-3747
Authors: Ausaf Ahmad and M. Anwar Iqbal

Implication of microRNAs in the Pathogenesis of MDS

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 22
Page: 3170-3179
Authors: Jing Fang, Melinda Varney and Daniel T. Starczynowski

Proteomic Strategies for Individualizing Therapy of Acute MyeloidLeukemia (AML)

Journal: Current Pharmaceutical Biotechnology
Volume: 7, Issue: 3
Page: 159-170
Authors: Gry Sjoholt, Siv Lise Bedringaas, Anne P. Doskeland and Bjorn Tore Gjertse

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 6, Issue: 8
Page: 671-679
Authors: A. Ferrajoli, S. Faderl, F. Ravandi and Z. Estrov

Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 13, Issue: 7
Page: 737-747
Authors: Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone

Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 5, Issue: 8
Page: 573-578
Authors: Domenico Ribatti and Angelo Vacca

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

Journal: Current Cancer Drug Targets
Volume: 4, Issue: 3
Page: 235-256
Authors: Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris

Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale Analysis of Rodent Cancer Models

Journal: Current Genomics
Volume: 2, Issue: 4
Page: 325-335
Authors: R. Kappler and H. Scherthan

Role of mTOR in Hematological Malignancies

Journal: Current Cancer Therapy Reviews
Volume: 4, Issue: 3
Page: 211-218
Authors: Uzma Athar and Ajeet Gajra

Rho-Signaling Pathways in Chronic Myelogenous Leukemia

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8, Issue: 4
Page: 261-267
Authors: Katerina Kuzelova and Zbynek Hrkal

Regulatory T Cells: Major Players in the Tumor Microenvironment

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 16
Page: 1879-1892
Authors: Marc Beyer and Joachim L. Schultze

Safety of the Thrombopoiesis-Stimulating Agents for the Treatment of Immune Thrombocytopenia

Journal: Current Drug Safety
Volume: 5, Issue: 2
Page: 171-181
Authors: Adam Cuker, Elaine Y. Chiang and Douglas B. Cines

Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 34
Page: 4114-4133
Authors: F. Anizon, A. A. Shtil, V. N. Danilenko and P. Moreau

Exploring Old Drugs for the Treatment of Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 10
Page: 1509-1514
Authors: F. Gan, B. Cao, D. Wu, Z. Chen, T. Hou and X. Mao

Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)]

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11, Issue: 9
Page: 780-781
Authors: Thomas P. Loughran and Hong-Gang Wang

Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11, Issue: 9
Page: 891-903
Authors: Valerie Gouaze-Andersson and Myles C. Cabot

Epidemiology and Prevention of Bacterial Infections in Patients with Hematologic Malignancies

Journal: Infectious Disorders - Drug Targets
Volume: 11, Issue: 1
Page: 11-17
Authors: Jeffrey Tessier and Costi D. Sifri

The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7, Issue: 9
Page: 877-887
Authors: C. Ulivieri and C. T. Baldari

Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10, Issue: 5
Page: 359-371
Authors: D. Subramaniam, S. Ramalingam, C.W. Houchen and S. Anant

Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 1, Issue: 3
Page: 241-258
Authors: Therakathinal T. Sreelekha and Vandana Viswanathan

Proteomics of p53 in Diagnostics and Therapy of Acute Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7, Issue: 3
Page: 199-207
Authors: Nina Anensen, Ingvild Haaland, Clive D'Santos, Werner Van Belle and Bjorn Tore Gjertsen

Targeting the EGFR Pathway for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 13, Issue: 29
Page: 3483-3492
Authors: James B. Johnston, Sri Navaratnam, Marshall W. Pitz, Jerry M. Maniate, Emilia Wiechec, Heinrich Baust, Joel Gingerich, Georgios P. Skliris, Leigh C. Murphy and Marek Los

Drug Resistance and Methylation in Myelodysplastic Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 8, Issue: 2
Page: 77-81
Authors: D. O. Vidal, L. F. Lopes and E. T. Valera

Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 5, Issue: 8
Page: 579-594
Authors: Jozef Dulak and Alicja Jozkowicz

Retinoids in Cancer Chemoprevention

Journal: Current Cancer Drug Targets
Volume: 4, Issue: 3
Page: 285-298
Authors: Masataka Okuno, Soichi Kojima, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Yasutoshi Muto, Scott L. Friedman and Hisataka Moriwaki

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins

Journal: Current Pharmaceutical Biotechnology
Volume: 2, Issue: 1
Page: 19-46
Authors: Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter